Evidence map›Paper›PMID 33935515›Full record

ReviewInternational journal of general medicine2021

Relationship Between

Yoshitaka Furuto, Mariko Kawamura, Jumpei Yamashita, Takahiro Yoshikawa, Akio Namikawa, Rei Isshiki, Hiroko Takahashi, Yuko Shibuya

Abstract readReview
In one paragraph

Review in International journal of general medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Glucolipid Metabolic Disorders andInternational journal of endocrinology · 2026
    Review
  2. Metabolism open · 2025
    Review
  3. Reviews in cardiovascular medicine · 2025
    Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Heliyon · 2023
    Article
  9. Association betweenThe Journal of international medical research · 2023
    Article
  10. Article
  11. Article
  12. Jiedu-Yizhi Formula Alleviates Neuroinflammation in AD Rats by Modulating the Gut Microbiota.Evidence-based complementary and alternative medicine : eCAM · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yoshitaka FurutoDepartment of Hypertension and Nephrology, NTT Medical Centre, Tokyo, Japan.ORCID 0000-0001-6851-1542
Mariko KawamuraDepartment of Hypertension and Nephrology, NTT Medical Centre, Tokyo, Japan.
Jumpei YamashitaDepartment of Hypertension and Nephrology, NTT Medical Centre, Tokyo, Japan.
Takahiro YoshikawaDepartment of Hypertension and Nephrology, NTT Medical Centre, Tokyo, Japan.
Akio NamikawaDepartment of Hypertension and Nephrology, NTT Medical Centre, Tokyo, Japan.ORCID 0000-0001-5659-6606
Rei IsshikiDepartment of Hypertension and Nephrology, NTT Medical Centre, Tokyo, Japan.
Hiroko TakahashiDepartment of Hypertension and Nephrology, NTT Medical Centre, Tokyo, Japan.
Yuko ShibuyaDepartment of Hypertension and Nephrology, NTT Medical Centre, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It is reported that

Indexed as

arteriosclerosisHelicobacter pylori infectionhypertension

Identifiers

PMID33935515
PMCPMC8079247

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.